XIENCE XPEDITION 1074225-18Recalls & reported problems
Abbott Vascular Inc. · XIENCE Xpedition SV Everolimus Eluting Coronary Stent System 2.25 mm x 18 mm / Rapid-Exchange · Class 3 · Implant
All models of XIENCE XPEDITION (41)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 4
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 08717648162046), received between Nov 11, 2016 and Nov 5, 2018 — classified as 2 injuries, 2 malfunctions.
The most frequently reported specific device problem is “Difficult to Remove” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem2
- Difficult to Remove1
- Material Rupture1
Patient problems
- Angina1
- Intimal Dissection1
- No Consequences Or Impact To Patient1
- No Patient Involvement1
- Non specific EKG/ECG Changes1
- Stenosis1
- Thrombosis1
Recent adverse event reports
The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.
MalfunctionNov 5, 2018Material Rupture; Material Rupture
IT WAS REPORTED THAT DURING A PROXIMAL MARGINAL ARTERY INTERVENTION, DURING DEPLOYMENT OF THE 2.25 X 18 MM XIENCE XPEDITION STENT AT 12 ATMOSPHERE (ATM), THE BALLOON WOULD NOT HOLD PRESSURE AND SLOWLY DEFLATED. THE BALLOON WAS INFLATED TWICE TO ENSURE THE STENT WAS WELL APPOSED TO THE VESSEL WALL AND THE RESULT WAS NOTED AS VERY GOOD. OUTSIDE THE ANATOMY, A MICRO HOLE WAS NOTED IN THE BALLOON AREA. THERE WAS NO REPORTED ADVERSE PATIENT EFFECT OR A CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 8040394 ↗MalfunctionApr 30, 2018Difficult to Remove
IT WAS REPORTED THE PROTECTIVE SHEATH GOT STUCK ON THE WIRE. NO ADDITIONAL INFORMATION WAS PROVIDED. RETURN DEVICE ANALYSIS NOTED THE TIP AND INNER MEMBER WERE SEPARATED.
Patient problems: No Patient Involvement
MAUDE report 7473950 ↗InjuryMar 2, 2017Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT THREE XIENCE XPEDITION STENTS (2.25 X 18 MM. 2.25 X 08 MM AND 3.0 X 12 MM) WERE IMPLANTED IN THE RIGHT CORONARY ARTERY ON (B)(6) 2014. ON (B)(6) 2017, THE PATIENT WAS RE-ADMITTED WITH CHEST PAIN AND RESTENOSIS IN THE STENTS WAS FOUND WHICH WAS TREATED WITH TWO NON-ABBOTT STENTS. THERE WAS NO CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE. THE PATIENT IS DOING GOOD. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: Angina; Stenosis
MAUDE report 6374875 ↗InjuryNov 11, 2016Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT THE PROCEDURE WAS TO TREAT A MILDLY TORTUOUS, MODERATELY CALCIFIED DE NOVO LESION IN THE PROXIMAL RIGHT CORONARY ARTERY (RCA). TWO XIENCE XPEDITION DRUG ELUTING STENTS WERE IMPLANTED. THE PATIENT WAS BROUGHT BACK TO THE LAB THE SAME DAY DUE TO ST ELEVATION AND ANGIOGRAPHY CONFIRMED THROMBOSIS IN THE PROXIMAL 2.25X18MM XIENCE XPEDITION STENT. THE THROMBOSIS WAS TREATED WITH A NON-ABBOTT CATHETER AND INTRACORONARY REOPRO. THE PATIENT WAS A NON-RESPONDER FOR PLAVIX AND WAS NOT ON ASPIRIN AT THE TIME OF THE THROMBOSIS. IT IS POSSIBLE THERE WAS A MECHANICAL EDGE DISSECTION. THE PROXIMAL STENT WAS POST-DILATED AND A LARGER STENT WAS PLACED PROXIMAL WITH GOOD RESULTS. THE PATIENT WILL BE ON TICAGRELOR FOR 12 MONTHS FOLLOWED BY TICAGRELOR AND WARFARIN FOR 6 MONTHS AND FINALLY ASPIRIN AND WARFARIN THEREAFTER. THERE WAS NO CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE. NO ADDITIONALLY INFORMATION WAS PROVIDED.
Patient problems: Intimal Dissection; Non specific EKG/ECG Changes; Thrombosis
MAUDE report 6096177 ↗
Other Coronary drug-eluting stent devices
- SYNERGY™ H7493926038300Boston Scientific Corporation · Coronary drug-eluting stent8 deaths124 reports
- SYNERGY™ H7493926016300Boston Scientific Corporation · Coronary drug-eluting stent7 deaths106 reports
- SYNERGY™ H7493926020300Boston Scientific Corporation · Coronary drug-eluting stent9 deaths90 reports
- SYNERGY™ H7493926016250Boston Scientific Corporation · Coronary drug-eluting stent6 deaths82 reports
- XIENCE Sierra™ 1550350-33Abbott Vascular Inc. · Coronary drug-eluting stent1 recall32 reports
- Resolute Onyx™ RONYX30022UXMedtronic, Inc. · Coronary drug-eluting stent6 deaths76 reports
- SYNERGY™ H7493926024300Boston Scientific Corporation · Coronary drug-eluting stent3 deaths75 reports
- Resolute Onyx™ RONYX30015UXMedtronic, Inc. · Coronary drug-eluting stent3 deaths73 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page